TD Cowen, Health Care

Avantor CEO to Speak at TD Cowen’s 45th Annual Health Care Conference
RADNOR, PA — Avantor, Inc. (NYSE: AVTR) has announced that its President and CEO, Michael Stubblefield, will be presenting at TD Cowen’s 45th Annual Health Care Conference. The presentation is
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston,
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference on Tuesday, March 4, 2025 at 11:10 A.M. ET.
Skye Bioscience to Present at TD Cowen Health Care Conference
Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation.
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday,
Snowflake in spotlight as TD Cowen sees 'constructive' partner checks ahead of Q4 results
Snowflake (NYSE:SNOW) was in the spotlight on Friday as TD Cowen said recent partner checks were “constructive” ahead of the ...
Walmart's future is bright, says TD Cowen's Oliver Chen
Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...
Analog Devices price target raised to $280 from $260 at TD Cowen
TD Cowen raised the firm’s price target on Analog Devices (ADI) to $280 from $260 and keeps a Buy rating on the shares. The firm said they ...
Charles Schwab (NYSE:SCHW) Upgraded by TD Cowen to “Buy” Rating
Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...
CRISPR upgraded to hold by TD Cowen on limited downside
TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...
TD Cowen Remains a Buy on Supernus Pharmaceuticals (SUPN)
TD Cowen analyst Stacy Ku maintained a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target of $44.00.
Investing15h
Walmart stock pullback a ‘buy opportunity,’ TD says
Investing.com-- TD Cowen analysts said a pullback in Walmart Inc (NYSE: WMT ), on weaker-than-expected guidance, represented a buy opportunity for the stock, and that they still saw the retail giant ...